Ocugen (OCGN) Other financing activities (2014 - 2026)
Ocugen (OCGN) reported Other financing activities of $1.8 million for Q1 2026, up 866.85% quarter-over-quarter from $184000.0 in Q2 2025.
Ocugen (OCGN) Other financing activities (2014 - 2026) Analysis & Trends
Ocugen has reported Other financing activities for 10 years, with the latest figure at $1.8 million in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities changed N/A year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at -$117000.0 (down 117.62% YoY), and the FY2025 full-year result was $1.5 million, up 88.63% from the prior year.
- Other financing activities for Q1 2026 stood at $1.8 million, up from $184000.0 in the prior quarter.
- The five-year high for Other financing activities was $2.8 million in Q3 2024, with the low at -$2.1 million in Q4 2024.
- Historically, Other financing activities has averaged $306333.3 across 5 years, with a median of $159000.0 in 2023.
- The largest YoY upside for Other financing activities was 1996.99% in 2024 against a maximum downside of 191.84% in 2024.
- Ocugen's Other financing activities stood at $506000.0 in 2022, then plunged by 73.72% to $133000.0 in 2023, then slumped by 1663.91% to -$2.1 million in 2024, then surged by 108.85% to $184000.0 in 2025, then soared by 866.85% to $1.8 million in 2026.
- The last three Other financing activities figures came in at $1.8 million (Q1 2026), $184000.0 (Q2 2025), and -$2.1 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.78 Mn |
| Mar 31, 2026 | 1.78 Mn |
| Jun 30, 2025 | 184,000.00 |
| Jun 30, 2025 | 184,000.00 |
| Dec 31, 2024 | -2.08 Mn |
| Dec 31, 2024 | -2.08 Mn |
| Sep 30, 2024 | 2.79 Mn |
| Sep 30, 2024 | 2.79 Mn |
| Jun 30, 2024 | -45,000.00 |
| Jun 30, 2024 | -45,000.00 |
| Mar 31, 2024 | 145,000.00 |
| Mar 31, 2024 | 145,000.00 |
| Sep 30, 2023 | 133,000.00 |
| Sep 30, 2023 | 133,000.00 |
| Jun 30, 2023 | 49,000.00 |
| Jun 30, 2023 | 49,000.00 |
| Mar 31, 2023 | 173,000.00 |
| Mar 31, 2023 | 173,000.00 |
| Dec 31, 2022 | 506,000.00 |
| Dec 31, 2022 | 506,000.00 |